Step into Yuanshu Pharmaceutical to learn more about our latest developments.
Yuan Shu Pharmaceutical’s project, “Research and Development of Aromatic Hydrocarbon‑Based Drug Intermediates for Age‑Related Diseases,” has been approved as a proposed key R&D and technological innovation project for Qixia District in 2021.
Release date:
2022-06-08
Author:
Yuan Shu Pharmaceutical
In accordance with the relevant requirements for managing science and technology program projects in Qixia District, the Qixia District Science and Technology Bureau organized and implemented two special programs under the district’s science and technology plan: the 2021 Key R&D and Technological Innovation Projects, and the Industry–University–Research Collaboration and Scientific and Technological Achievement Transformation Projects. Among these, Yuanshu Pharmaceutical Technology Co., Ltd. ’s project titled “Research and Development of Aromatic Hydrocarbon Drug Intermediates for Geriatric Diseases” successfully passed the preliminary approval process—including eligibility review, on-site assessment, and expert evaluation—and has been publicly announced as a proposed project.
Inquiry and Consultation
Please complete the relevant information, and our customer service team will contact you promptly to send you the materials.
Latest Updates
Contact Information
Switchboard:025-84823631
Sales:025-84823350
General Manager:13601462659
Email:admin@yspharma.com
Address: Rooms 404–408 and 309–313, Building F7, Jiangsu Life Science Innovation Park, No. 9 Weidi Road, Xianlin Subdistrict, Qixia District, Nanjing, Jiangsu Province
Copyright © 2026 Yuanshu Pharmaceutical Technology Co., Ltd.
-
-
Sales
-
General Manager
-
Email box
-
